Chemical inhibitors of Nef can exert their effects through various biochemical and cellular pathways. Curcumin directly binds to Nef, disrupting its ability to interact with host cell proteins that are crucial for HIV-1's pathogenicity. By physically obstructing these interactions, Curcumin impedes Nef's function. Similarly, Bay 11-7082 targets the NF-κB pathway, a signaling cascade that Nef exploits to enhance HIV replication and immune evasion. By inhibiting NF-κB, Bay 11-7082 curtails the pathogenic influence of Nef. Chloroquine operates by increasing endosomal pH, which hampers the trafficking and subsequent activity of Nef within the cell, effectively limiting its ability to aid in immune system evasion. PD 98059 and U0126 both inhibit MEK1/2, which are downstream components of signaling pathways that Nef may use to boost HIV infectivity. Their inhibition of MEK consequently obstructs the pathways Nef would typically manipulate.
Cyclosporin A inhibits calcineurin, thereby impacting T-cell activation and apoptosis pathways that Nef modifies to support viral replication and persistence. GW5074, a c-Raf kinase inhibitor, disrupts downstream signaling that Nef uses to down-modulate MHC-I molecules, crucial for immune system recognition of infected cells. Inhibition by GW5074 thus impedes Nef's ability to prevent immune detection. Dasatinib interrupts Src family kinases, which are involved in actin cytoskeleton remodeling, a process essential for Nef's influence on host cell morphology and signaling. Rapamycin, an mTOR inhibitor, impairs cell growth and proliferation pathways that Nef leverages, thereby hampering the protein's pathogenic effects. LY294002 impedes the PI3K/Akt signaling pathway, countering the survival pathways that Nef engages to prevent apoptosis of HIV-infected cells. SP600125 targets JNK, disrupting the signaling pathways Nef manipulates for enhancing viral propagation and cellular signaling. Lastly, SB203580 inhibits p38 MAPK, which is involved in inflammatory and stress responses that Nef can utilize to promote HIV-1 replication and pathogenicity, thereby limiting Nef's functional effects. Each of these chemicals, through their distinct mechanisms, serve to inhibit the functional activity of the Nef protein within its associated pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin inhibits HIV-1 Nef protein by directly binding to it and interfering with its interaction with host cell proteins required for its pathogenic effects. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Bay 11-7082 inhibits the NF-κB pathway, which is utilized by HIV-1 Nef to enhance viral replication and pathogenesis. Inhibition of NF-κB leads to reduced Nef functionality. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine raises endosomal pH, which can interfere with the trafficking of the Nef protein and its associated host cell protein interactions critical for immune evasion. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD 98059 inhibits MEK, which is downstream of the signaling pathways that Nef interacts with. By inhibiting MEK, the downstream effects of Nef on enhancing viral infectivity and replication can be reduced. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A inhibits calcineurin, which indirectly affects the pathways Nef uses to modulate T cell activation and apoptosis, leading to inhibition of these Nef-mediated effects. | ||||||
GW 5074 | 220904-83-6 | sc-200639 sc-200639A | 5 mg 25 mg | $106.00 $417.00 | 10 | |
GW5074 is a c-Raf kinase inhibitor, which can disrupt signaling pathways that Nef hijacks to down-modulate MHC-I molecules on the infected cell surface, therefore hindering Nef's ability to evade immune detection. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Dasatinib, by inhibiting Src family kinases, can alter the actin cytoskeleton remodeling that is necessary for Nef's effects on host cell morphology and signal transduction. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
U0126 inhibits MEK1/2, key components in the ERK signaling pathway that Nef may utilize to enhance HIV-1 infectivity and replication. Inhibition of this pathway impairs Nef function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in controlling cell growth and proliferation. Since Nef modulates these processes to favor HIV-1 replication, mTOR inhibition can impair Nef's pathogenic effect. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, and by inhibiting PI3K/Akt signaling, it can interfere with the survival pathways that Nef engages to prevent apoptosis of the infected cell, thereby inhibiting Nef's ability to protect HIV-infected cells. | ||||||